Sharda Cropchem Limited has informed the Exchange about Investor Presentation
30th October, 2025
To,
National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
BSE Limited Phiroze Jeejeebhoi Tower, Dalal Street, Mumbai – 400 001
Trading Symbol: SHARDACROP
Scrip Code: 538666
Subject: Investors / Analyst’s Presentation for the Quarter and half year ended 30th September, 2025.
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we are enclosing herewith the presentation to be made to the Investors/Analysts on the Financial Results of the Company for the quarter & half year ended 30th September, 2025.
The presentation is also being uploaded on the website of the Company www.shardacropchem.com the Listing Regulations.
in accordance with Regulation 46 of
We request you to take the same on record.
Yours Sincerely,
__________________ Jetkin Gudhka Company Secretary & Compliance Officer
Encl.: As above
GROWING STRONGER, GOING FURTHER.
Investor Presentation October 2025
SAFE HARBOR
This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions.
This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate.
Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks.
This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes.
GROWING STRONGER, GOING FURTHER.
2
About Sharda Cropchem Limited
“We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North America and Latin America. It equips us with the ability to operate in a diversified range of formulations and generic active ingredients space globally”
AGROCHEMICAL FOCUSED COMPANY
Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients
Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency of identifying generic molecules and registration opportunities which offer scalable growth with limited capital requirements
Large Pipeline of Registrations* : Procured 2,994 registrations. Additionally, it has filed 1,068 applications for registrations globally pending at different stages
Diversified Sourcing Arrangements : Enduring relationship with multiple manufacturers and formulators enables to source and supply formulations or generic active ingredients at competitive prices
Consistently Increasing Global Presence : With diversified range of product portfolio, Company has grown by expanding business operations in 80+ countries, across Europe, NAFTA, Latin America and ROW
Widespread Distribution Network : Presence in the entire agrochemical value chain with 525 third party distributors and 500+ sales force serving the Company’s esteemed clientele in 80+ countries
*As on 30th September 2025
Company’s apt domain knowledge and experience gives substantial competitive advantage for expanding business in existing markets and new geographies
ASSET LIGHT BUSINESS MODEL
Overall Agrochemical Value Chain
Sharda’s Operating Area
√
√
√
√
Basic & Applied Research
Identification
Registration
Active Ingredient Manufacturing
Formulation & Packaging
Marketing & Distribution
Focus on identification of generic molecules, preparing dossiers, seeking registrations, marketing & distributing formulations through third-party distributors and/or own sales force
Manufacturing of AIs and formulations is outsourced
Acts as a key differentiator from an innovator company, allowing the Company to save its capital, time and resources on R&D
Highly flexible operating model resulting in :
• Overall cost competitiveness • Efficient management of fluctuating market demand across various geographies
• Offering wide range of formulations and AIs
GROWING STRONGER, GOING FURTHER.
6
INCREASING GLOBAL PRESENCE WITH WIDESPREAD DISTRIBUTION
Presence
80+ countries
across Europe, NAFTA, LATAM & RoW
Global Resource Deployment
500+
Distributors
525+
CAPEX incurred in H1 FY26 Rs. 250 Cr.
Over the years, the Company has built a strong brand franchise within our global markets; we are benefiting through the economies of scale in our portfolio and leveraging value of our supply chain to deliver value to our customers across geographies
In addition to newer markets, the wide global presence has allowed us to find new, specialised sales and local marketing talent.
Successfully adopted a factory-to- farmer approach to become a one- stop solution provider to our global customers
Strengthening and widening the sales force in Europe, USA, Canada, Mexico, Colombia, South Africa, India, and rest of the world, in addition to third party distributors with a goal to enhance its presence in the agrochemical value chain
It enables the Company to penetrate its formulations and generic active ingredients in various countries backed by the third-party distributors and presence of its own sales force
Company has gained a great deal from globalization, including new customers and diverse geocentric revenue streams. Over the years, we have mastered flexibility and adopted innovative ways to grow our business overseas
GROWING STRONGER, GOING FURTHER.
7
The Sharda Advantage
Global Reach
Wide Product Range
Healthy Relationships with Suppliers
Quality with Affordability
Faster Sales Service
One Stop Solution Provider for Crop Care Products
WAY FORWARD
Forward Integration - Build Sales Force
✓ Leverage market presence and execution capabilities
✓ Adopt the factory to farmer approach and be a one stop
solution provider
✓ Strategy on ground in different regions of NAFTA, Europe,
LATAM and other key markets in ROW
1
3
Expand & Strengthen Distribution Presence
✓ Expand geographical reach using existing library of dossiers
✓ Two-fold strategy of further penetrating existing markets and
entering new markets
2
4
Continual Investment in Product Registrations
✓ Continue to identify generic molecules going off patent
✓ Investing in preparing dossiers and seeking registrations in
own name
Focus on Operational Efficiencies
✓ Accelerated focus on revenue generating investments
✓ Margin improvements
✓ Better cost management and eliminate NVAs
GROWING STRONGER, GOING FURTHER.
9
INDUSTRY OUTLOOK & GROWTH DRIVERS
Global crop protection (In Billion USD) – CAGR of 3.96%
INDUSTRY DRIVERS
+3.96%
141.7
96.1
FY24
FY33e
Source : Annual Report (FY25)
A Growing Population: Global population is projected to rise from 7.6 Bn in 2025 to 8.6 Bn by 2030 and 9.8 Bn by 2050 placing unprecedented pressure on global food and protein systems
A growing middle class fuels demand for increased food and protein production, which in turn drives demand for grain to support growth
Fewer arable acres per capita means that products need to continue to maximise farmer yields; arable land is expected to decrease from half an acre per person today to less than one-third of an acre per person by 2050
GROWING STRONGER, GOING FURTHER.
10
Experienced Management
Mr. Ramprakash V. Bubna Chairman & Managing Director
Mr. Ashish Bubna Whole Time Director
Mr. Manish Bubna Whole Time Director
✓ Holds a Bachelor’s Degree of Technology in Chemical
✓ Holds a Bachelor’s Degree in Commerce from the
Engineering from IIT, Bombay
University of Mumbai
✓ Holds a Bachelor’s Degree in Chemical Engineering from the Department of Chemical Technology, Bombay University.
✓ He has over 57 years of experience in chemicals,
✓ Over 34 years of experience in marketing of chemicals,
✓ Over 32 years of experience in chemicals, agrochemicals and
agrochemicals and related businesses
agrochemicals and related businesses.
related businesses
✓ He is responsible for the Company’s overall business
✓ Instrumental in strategizing early investment in product
✓ Spearheaded the Company’s foray into the conveyor belt and
operations and strategy
registrations and building the library of product dossiers.
✓ Responsible for marketing, procurement, registrations and logistics functions of the agrochemical business.
general chemicals business
✓ Also oversees the information technology, logistics and
documentation functions of the Company
Q2 FY26 Financial Highlights
Q2 FY26: SEGMENT WISE HIGHLIGHTS
Agrochemical Segment
Non-Agrochemical Segment
TOTAL REVENUES
Cr.
82%
86%
18%
14%
100%
100%
+27%
803
-11%
143
634
126
777
+20%
929
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
GROWING STRONGER, GOING FURTHER.
Q2 FY25
Q2 FY26
% of Revenue
On Consolidated Basis
13
Q2 FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment)
Herbicides
Insecticides
Fungicides
Cr.
TOTAL REVENUES (Agrochemical Segment)
57%
54%
21%
27%
22%
19%
100%
100%
+20%
433
361
+65%
219
133
+7%
150
141
+27%
803
634
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
14
Q2 FY26: REGION WISE BREAKUP (Agrochemical Segment)
Europe
+15%
58%
463
64%
404
NAFTA Region
20%
126
+69%
27%
214
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
LATAM Region
9%
58
+21%
9%
71
RoW
+21%
6%
55
7%
46
Cr.
TOTAL REVENUES (Agrochemical Segment)
+27%
803
634
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
GROWING STRONGER, GOING FURTHER.
Q2 FY25
Q2 FY26
% of Revenue
On Consolidated Basis
15
Q2 FY26: REGION WISE BREAKUP (Non - Agrochemical Segment)
Europe
+4%
20%
25
17%
24
NAFTA Region
65%
92
-15%
62%
78
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
LATAM Region
5%
7
+53%
9%
11
RoW
-37%
13%
19
9%
12
Cr.
TOTAL REVENUES (Non - Agrochemical Segment)
-11%
143
126
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
GROWING STRONGER, GOING FURTHER.
Q2 FY25
Q2 FY26
% of Revenue
On Consolidated Basis
16
Q2 FY26 : FINANCIAL HIGHLIGHTS
Revenues & GP Margin
27.6%
34.5%
+20%
929
777
EBITDA
+71%
139
Cr.
Profit After Tax
+75%
74
81
42
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
Q2 FY25
Q2 FY26
✓ Revenue in Q2 FY26 increased by 20% primarily driven by high volume growth of ~35%. We saw volume growth across all regions
✓ Agrochemical volumes grew by 36.1% in Q2 FY26
✓ Non-Agrochemical volumes grew by 10.9% in Q2 FY26
✓ Gross Margins have improved 690 basis points to 34.5%. These margins are expected to remain at these levels in FY26 supported by lower input costs and improved price realizations
✓ EBITDA for the quarter grew by 71% to Rs. 139 crores with EBITDA Margins at 15% showcasing improvement by 450 bps as compared to Q2 FY25
✓ PAT for the quarter grew by 75% to Rs. 74 crores as compared to Rs. 42 crores in Q2 FY25
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
17
H1 FY26 Financial Highlights
H1 FY26: SEGMENT WISE HIGHLIGHTS
Agrochemical Segment
Non-Agrochemical Segment
TOTAL REVENUES
Cr.
84%
86%
16%
14%
% of Revenue
100%
100%
+26%
1,649
1,313
+7%
265
249
+23%
1,914
1,562
H1 FY25
H1 FY26
H1 FY25
H1 FY26
H1 FY25
H1 FY26
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
19
H1 FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment)
Herbicides
Insecticides
Fungicides
Cr.
TOTAL REVENUES (Agrochemical Segment)
52%
52%
22%
26%
27%
23%
% of Revenue
100%
100%
+26%
853
680
+48%
424
286
+7%
372
348
+26%
1,649
1,313
H1 FY25
H1 FY26
H1 FY25
H1 FY26
H1 FY25
H1 FY26
H1 FY25
H1 FY26
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
20
H1 FY26: REGION WISE BREAKUP (Agrochemical Segment)
Europe
+28%
60%
985
58%
768
NAFTA Region
29%
375
+25%
28%
469
H1 FY25
H1 FY26
H1 FY25
H1 FY26
LATAM Region
7%
98
+20%
7%
118
RoW
+6%
5%
76
6%
72
Cr.
TOTAL REVENUES (Agrochemical Segment)
+26%
1,649
1,313
H1 FY25
H1 FY26
H1 FY25
H1 FY26
GROWING STRONGER, GOING FURTHER.
H1 FY25
H1 FY26
% of Revenue
On Consolidated Basis
21
H1 FY26: REGION WISE BREAKUP (Non - Agrochemical Segment)
Europe
+16%
18%
47
16%
40
NAFTA Region
64%
160
+7%
64%
171
H1 FY25
H1 FY26
H1 FY25
H1 FY26
LATAM Region
8%
19
+20%
9%
23
RoW
-15%
12%
29
9%
24
Cr.
TOTAL REVENUES (Non - Agrochemical Segment)
+7%
265
249
H1 FY25
H1 FY26
H1 FY25
H1 FY26
GROWING STRONGER, GOING FURTHER.
H1 FY25
H1 FY26
% of Revenue
On Consolidated Basis
22
H1 FY26 : FINANCIAL HIGHLIGHTS
Revenues & GP Margin
28.4%
35.0%
+23%
1,914
1,562
167
EBITDA
+69%
281
Cr.
Profit After Tax
+212%
217
70
H1 FY25
H1 FY26
H1 FY25
H1 FY26
H1 FY25
H1 FY26
✓ Revenue in H1 FY26 increased by 23% primarily driven by higher volume growth of 24%. We saw volume growth across all regions, with Europe being the key contributor
✓ Agrochemical volumes grew by 23.4% in H1 FY26
✓ Non-Agrochemical volumes grew by 31.2% in H1 FY26
✓ Gross Margins have increased to 35.0% and it is expected to remain in the similar range for FY26
✓ EBITDA for the half year stood at Rs. 281 crores as compared to Rs. 167 crores in H1 FY25, a growth of 69%
✓ PAT for H1FY26 stood at Rs. 217 crores as compared to of Rs. 70 crores in H1 FY25, a growth of 212%
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
23
STRONG BALANCE SHEET
Working Capital (in Days)
Total Equity
118 days
146
83
111
84 days
Reduced Working Capital by 34 days
93
88
96
Mar-25
Sep-25
Inventory Days
Recievable Days
Creditor Days
RoCE*
21.6%
RoE*
17.5%
Rs. 2,676 crores*
Rs. 2,501 crores as on Mar’25
Cash, Bank & Liquid Investments
Rs. 794 crores*
Rs. 558 crores as on Mar’25
* ROCE = EBIT / Average Capital Employed ; RoE = PAT / Average Equity (On TTM Basis) * As on 30th September 2025
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
24
Annexure
Q2 & H1 FY26 FINANCIAL HIGHLIGHTS
Particulars
Revenue from Operations
COGS
Gross Profit
Gross Margin %
Employee Expenses
Other Expenses
EBITDA
EBITDA Margin %
Forex (Gain)/Loss
Depreciation
Other Income
EBIT
EBIT Margin %
Finance Cost
PBT
Tax Expense
PAT
PAT Margin %
Earnings Per Share (EPS) In Rs.
Q2 FY26
Q2 FY25
929.1
608.4
320.7
34.5%
12.3
169.5
138.9
15.0%
6.1
76.2
29.4
86.1
9.3%
0.3
85.7
11.4
74.4
8.0%
8.24
776.9
562.2
214.7
27.6%
10.4
123.0
81.3
10.5%
(19.4)
69.1
14.4
46.0
5.9%
0.5
45.5
3.1
42.4
5.5%
4.70
Y-o-Y
20%
49%
71%
87%
88%
75%
H1 FY26
1,913.9
1,244.0
H1 FY25
1,562.0
1,118.4
669.9
35.0%
27.3
361.5
281.1
14.7%
(67.0)
154.3
61.9
255.8
13.4%
0.9
254.9
37.7
217.2
11.3%
24.06
443.6
28.4%
21.5
255.4
166.7
10.7%
(11.1)
133.9
33.7
77.5
5.0%
1.2
76.3
6.6
69.7
4.5%
7.72
Cr.
Y-o-Y
23%
51%
69%
230%
234%
212%
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
26
BALANCE SHEET
EQUITY & LIABILITIES Equity Equity share capital Other equity Equity attributable to equity holders of the Company Non-controlling interests Total Equity Non-current liabilities Financial liabilities Lease liabilities Other financial liabilities Provisions Deferred tax liabilities (net) Total non-current liabilities Current liabilities Financial liabilities Borrowings Lease liabilities Trade payables
total outstanding dues of micro enterprises and small
enterprises
other than micro enterprises and small enterprises
Other financial liabilities Other current liabilities Provisions Current tax liabilities Total current liabilities Total Equity & Liabilities
Sep-25
Mar-25
90.2 2,585.2 2,675.5 0.5 2,675.9
- 30.6 0.3 172.4 203.3
- 4.0
3.2
1,320.2 538.5 77.3 75.7 4.9 2,023.9 4,903.1
90.2 2,410.3 2,500.6 0.4 2,501.0
- 63.0 1.3 173.8 238.1
- 7.8
5.1
1,305.1 501.3 104.7 57.6 4.2 1,985.7 4,724.9
ASSETS Non-current assets Property, plant and equipment Right to use assets Intangible assets Intangible assets under development Financial assets Other Financial Assets Other non-current assets Income tax assets (net) Deferred Tax Assets Total non-current assets Current assets Inventories Financial assets Investments Trade receivables Cash and cash equivalents Bank balance other than cash and cash equivalents Loans Other financial assets Other current assets Total current assets Total Assets
GROWING STRONGER, GOING FURTHER.
Sep-25
Mar-25
Cr.
2.9 3.6 810.8 291.6
122.3 18.4 32.7 16.4
3.0 7.2 740.2 291.4
5.4 16.4 63.4 11.6
1,298.6
1,138.5
1,418.9
971.9
554.7 1,233.2 165.3 62.5 - 22.2 147.7 3,604.5 4,903.1
294.3 1,955.4 127.2 93.1 - 47.5 96.8 3,586.4 4,724.9
On Consolidated Basis
27
CASH FLOW STATEMENT
Particulars
Profit Before Tax
Adjustments
Operating profit before working capital changes
Changes in working capital
Cash generated from operations
Direct taxes paid (net of refund)
Net Cash from Operating Activities
Net Cash from Investing Activities
Net Cash from Financing Activities
Exchange difference arising on conversion (debited) / credited to foreign currency translation reserve
Net Change in cash and cash equivalents
Opening Cash Balance
Effect of exchange rate changes on cash & cash equivalents held in foreign currencies
Closing Cash Balance
H1 FY26
H1 FY25
Cr.
254.9
126.5
381.4
229.0
610.3
(5.2)
605.2
(523.8)
(59.3)
11.9
34.0
127.2
4.1
165.3
76.3
100.6
176.9
321.6
498.5
(40.8)
457.8
(329.3)
(34.5)
14.0
108.0
87.3
0.7
196.1
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
28
KEY FINANCIAL PERFORMANCE INDICES
Revenue
EBITDA & EBITDA Margin*
Profit After Tax & PAT Margin
Cr.
19.0%
20.4%
17.6%
10.1%
15.8%
9.6%
9.8%
8.5%
1.0%
7.0%
3,580
4,045
3,163
4,320
2,396
729
713
682
349
342
455
318
229
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
304
FY25
32
FY24
RoCE
RoE
Cash, Bank & Liquid Investments^
25.7%
20.2%
20.8%
19.8%
16.5%
15.2%
16.0%
3.4%
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
* EBITDA is excluding IA & IAUD write-off
^ Total Cash & Cash Equivalents (Includes FDs of Rs. 128 crores clubbed in Non Current Other Financial Assets)
GROWING STRONGER, GOING FURTHER.
12.8%
276
262
325
375
558
1.4%
FY24
FY25
FY21
FY22
FY23
FY24
FY25
On Consolidated Basis
29
HISTORICAL PROFIT & LOSS
Particulars
Revenue from Operations
COGS
Gross Profit
Gross Margin %
Employee Expenses
Other Expenses
EBITDA*
EBITDA Margin %
Forex (Gain)/Loss
Depreciation
Other Income
EBIT
EBIT Margin %
Finance Cost
PBT
Tax Expense
PAT
PAT Margin %
Earnings Per Share (EPS) In Rs.
* EBITDA is excluding IA & IAUD write-off
FY25
4,319.9
3,028.1
1,291.8
29.9%
52.0
626.3
681.6
15.8%
17.9
274.7
59.5
380.4
8.8%
2.1
378.3
73.9
304.4
7.0%
33.74
FY24
3,163.0
2,342.4
820.6
25.9%
42.4
494.9
318.1
10.1%
0.4
267.1
59.8
75.5
2.4%
3.6
71.9
40.0
31.9
1.0%
3.53
FY23
4,045.2
2,860.8
1,184.4
29.3%
44.8
438.9
712.6
17.6%
57.6
248.1
40.3
435.3
10.8%
4.5
430.7
88.8
342.0
8.5%
37.90
FY22
3,579.8
2,499.8
1,080.0
30.2%
44.2
336.4
728.6
20.4%
16.5
245.3
28.9
466.5
13.0%
2.2
464.2
115.0
349.3
9.8%
38.71
Cr.
FY21
2,395.6
1,636.0
759.7
31.7%
37.3
305.5
455.2
19.0%
-19.9
170.4
45.9
312.2
13.0%
2.8
309.5
80.2
229.2
9.6%
25.40
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
30
BALANCE SHEET – EQUITY & LIABILITIES
Equities & Liabilities Shareholder's Funds Equity and Share Capital Other Equity Non-controlling Interest Total Equity
Non-Current Liabilities Borrowings Trade Payables Lease Liabilities Other Financial Liabilities Provisions Deferred Tax Liabilities (net) Total Non-Current Liabilities
Current Liabilities Borrowings Lease Liabilities Trade Payables Other Financial Liabilities Other Current Liabilities Current Tax Liabilities Provisions Total Current Liabilities Total Equity & Liabilities
FY25
90.2 2,410.4 0.4 2,501.0
- - - 63.0 1.3 173.8 238.1
- 7.8 1,310.2 501.3 104.7 4.2 57.6 1,985.7 4,724.9
FY24
90.2 2,146.9 0.4 2,237.5
- - 7.8 58.4 1.4 152.8 220.3
3.4 7.2 921.2 502.5 69.0 1.5 76.0 1,580.5 4,038.3
FY23
90.2 2,141.8 0.4 2,232.4
- - - 1.7 2.7 143.4 147.9
3.0 0.0 1,377.6 431.4 78.1 61.4 19.1 1,970.6 4,350.8
FY22
90.2 1,822.2 0.3 1,912.8
- 2.4 3.5 1.6 2.3 128.9 138.6
38.0 5.1 1,177.6 324.8 55.4 4.2 86.7 1,691.8 3,743.1
Cr.
FY21
90.2 1,524.1 0.3 1,614.6
- 2.4 8.4 3.2 3.0 92.9 109.9
67.8 4.5 806.8 149.1 58.0 3.2 50.0 1,139.4 2,863.9
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
31
BALANCE SHEET – ASSETS
ASSETS Assets Non-Current Assets Property, Plant and Equipment Right to Use Assets Goodwill Other Intangible assets Intangible assets under development Deferred Tax Assets (net) Non-Current Tax Assets Other financial assets Other Non Current Assets Total Non-Current Assets
Current Assets Inventories Investments Trade Receivables Cash & Cash equivalents Other Bank balances Loans Other Financial Assets Other Current Assets Total Current Assets Total Assets
FY25
FY24
FY23
FY22
3.0 7.2 0.0 740.2 291.4 11.6 63.4 5.4 16.4 1,138.5
971.9 294.3 1,955.4 127.2 93.1 0.0 47.5 96.8 3,586.4 4,724.9
3.8 14.4 0.0 690.0 282.9 10.3 72.1 5.3 21.7 1,100.4
991.6 158.9 1,498.0 87.3 0.6 0.0 128.1 73.4 2,937.9 4,038.3
5.0 0.0 0.0 663.0 203.9 7.9 72.3 120.7 19.9 1,092.7
1,134.3 31.9 1,833.3 176.4 0.2 0.0 5.5 76.5 3,258.2 4,350.8
14.4 - 0.0 577.4 212.2 4.9 71.6 11.2 0.0 891.7
892.8 134.4 1,540.0 56.7 109.3 0.5 48.9 68.9 2,851.5 3,743.1
Cr.
FY21
20.9 - 0.4 523.1 131.0 6.0 73.6 9.4 0.0 764.5
525.5 83.0 1,162.6 85.6 175.0 - 28.1 39.6 2,099.3 2,863.9
GROWING STRONGER, GOING FURTHER.
On Consolidated Basis
32
CSR ACTIVITIES
CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects
Promoting Education
Animal Welfare
Medical Aid & Relief
GROWING STRONGER, GOING FURTHER.
33
GROWING STRONGER, GOING FURTHER.
THANK YOU
Company: Sharda Cropchem Limited
Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd.
CIN: L51909MH2004PLC145007
CIN: U74140MH2010PTC204285
Mr. Shailesh Mehendale – CFO cfo@shardaintl.com / finance@shardaintl.com Tel: +91 22 6678 2800
Mr. Deven Dhruva / Ms. Jinal Shah deven.dhruva@sgapl.net / jinal.shah@sgapl.net Tel: +91 98333 73300 / +91 97692 69759